Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 46, 2017 - Issue 4
175
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Differential Expression of Toll-Like Receptor Signaling Pathway Is Associated with Microscopic Polyangiitis in Peripheral Blood Neutrophils

, , , , , , , , & show all

References

  • Ananieva O, Darragh J, Johansen C, et al. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol, 9, 1028–36.
  • Brandt KJ, Fickentscher C, Boehlen F, et al. 2014. NF-kappa B is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes. J Thromb Haemost, 12, 779–91.
  • Calderwood JW, Williams JM, Morgan MD, et al. 2005. ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium. J Leukoc Biol, 77, 33–43.
  • Eike MC, Skinningsrud B, Ronninger M, et al. 2012. CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations. Genes Immun, 13, 431–36.
  • Falk RJ, Terrell RS, Charles LA, et al. 1990. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA, 87, 4115–9.
  • Gyllenberg A, Asad S, Piehl F, et al. 2012. Age-dependent variation of genotypes in MHC II transactivator gene (CIITA) in controls and association to type 1 diabetes. Genes Immun, 13, 632–40.
  • Gyllenberg A, Piehl F, Alfredsson L, et al. 2014. Variability in the CIITA gene interacts with HLA in multiple sclerosis. Genes Immun, 15, 162–67.
  • Hasan U, Chaffois C, Gaillard C, et al. 2005. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol, 174, 2942–50.
  • Holle JU, Windmoller M, Lange C, et al. 2013. Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis. Rheumatology (Oxford), 52, 1183–9.
  • Honda K, Yanai H, Negishi H, et al. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature, 434, 772–7.
  • Huang GH, Wang YY, Vogel P, et al. 2012. Signaling via the kinase p38 alpha programs dendritic cells to drive T(H)17 differentiation and autoimmune inflammation. Nat Immunol, 13, 152–61.
  • Huang GH, Wang YY, Vogel P, et al. 2015. Control of IL-17 receptor signaling and tissue inflammation by the p38 alpha-MKP-1 signaling axis in a mouse model of multiple sclerosis. Sci Signaling, 8, 1–21.
  • Hubbard LL, Ballinger MN, Thomas PE, et al. 2010. A role for IL-1 receptor-associated kinase-M in prostaglandin E2-induced immunosuppression post-bone marrow transplantation. J Immunol, 184, 6299–308.
  • Jennette JC, Falk RJ, Bacon PA, et al. 2013. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum, 65, 1–11.
  • Kan QC, Zhu L, Liu N, et al. 2013. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity. Immunol Res, 56, 189–96.
  • Kim C, Sano Y, Todorova K, et al. 2008. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol, 9, 1019–27.
  • Krementsov DN, Noubade R, Dragon JA, et al. 2014. Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells. Ann Neurol, 75, 50–66.
  • Lech M, Kulkarni OP, Pfeiffer S, et al. 2008. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J Exp Med, 205, 1879–88.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402–8.
  • Ludviksson BR, Sneller MC, Chua KS, et al. 1998. Active Wegener’s granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol, 160, 3602–9.
  • Mullen GE, Kennedy MN, Visintin A, et al. 2003. The role of disulfide bonds in the assembly and function of MD-2. Proc Natl Acad Sci USA, 100, 3919–24.
  • Pegu A, Qin S, Fallert Junecko BA, et al. 2008. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol, 180, 3399–405.
  • Ramaiah SKV, Gunthner R, Lech M, et al. 2013. Toll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosis. Int J Mol Sci, 14, 13213–30.
  • Schonermarck U, Csernok E, Trabandt A, et al. 2000. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol, 18, 457–63.
  • Schreiber A, Luft FC and Kettritz R. 2015. Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GN. J Am Soc Nephrol 26: 411–24.
  • Tadema H, Abdulahad WH, Stegeman CA, et al. 2011. Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. PLoS One, 6, e24315.
  • Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell, 140, 805–20.
  • Tamaki Y, Takakubo Y, Hirayama T, et al. 2011. Expression of toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol, 38, 810–20.
  • Wang H, Gou SJ, Zhao MH, et al. 2014. The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin Exp Immunol, 177, 603–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.